1. Home
  2. NTHI vs HYPR Comparison

NTHI vs HYPR Comparison

Compare NTHI & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$3.44

Market Cap

114.6M

Sector

Health Care

ML Signal

HOLD

Logo Hyperfine Inc.

HYPR

Hyperfine Inc.

HOLD

Current Price

$0.96

Market Cap

94.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTHI
HYPR
Founded
2008
2014
Country
United States
United States
Employees
5
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.6M
94.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NTHI
HYPR
Price
$3.44
$0.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$15.00
$1.59
AVG Volume (30 Days)
65.4K
1.0M
Earning Date
05-19-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.21
EPS
N/A
N/A
Revenue
N/A
$13,563,000.00
Revenue This Year
N/A
$50.75
Revenue Next Year
N/A
$29.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.22
52 Week Low
$3.01
$0.85
52 Week High
$12.99
$2.22

Technical Indicators

Market Signals
Indicator
NTHI
HYPR
Relative Strength Index (RSI) 35.86 32.37
Support Level $3.01 $0.88
Resistance Level $4.59 $1.19
Average True Range (ATR) 0.38 0.07
MACD -0.03 -0.00
Stochastic Oscillator 25.55 16.34

Price Performance

Historical Comparison
NTHI
HYPR

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.

Share on Social Networks: